Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma
Journal of Neuro-Oncology · 2024
DOI: 10.1007/s11060-024-04592-8 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Neuro-Oncology, 2024. Verfasst von Jason P Sheehan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of Virginia, 1215 Lee St, 22908, Charlottesville, VA, USA. jsheehan@virginia.edu. Hauptthemen laut MEDLINE: Glioblastoma, Radiosurgery, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurological Surgery, University of Virginia, 1215 Lee St, 22908, Charlottesville, VA, USA. jsheehan@virginia.edu.
- Department of Neurological Surgery, University of Virginia, 1215 Lee St, 22908, Charlottesville, VA, USA.
- Department of Neurology, University of Columbia, New York City, NY, USA.
Zitieren
APA
Sheehan, J. P., Mantziaris, G., & Bunevicius, A. (2024). Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04592-8
Vancouver
Sheehan JP, Mantziaris G, Bunevicius A. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma. Journal of Neuro-Oncology. 2024. doi:10.1007/s11060-024-04592-8
BibTeX
@article{Sheehan2024,
author = {Sheehan, Jason P and Mantziaris, Georgios and Bunevicius, Adomas},
title = {Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma},
journal = {Journal of Neuro-Oncology},
year = {2024},
doi = {10.1007/s11060-024-04592-8}
}
EUVIMED